NALDI, MARINA
 Distribuzione geografica
Continente #
NA - Nord America 6.505
AS - Asia 5.092
EU - Europa 4.956
AF - Africa 362
SA - Sud America 274
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 6
Totale 17.211
Nazione #
US - Stati Uniti d'America 6.426
SG - Singapore 1.521
CN - Cina 1.509
IT - Italia 1.106
GB - Regno Unito 1.087
VN - Vietnam 875
DE - Germania 629
SE - Svezia 535
HK - Hong Kong 398
IN - India 336
RU - Federazione Russa 268
UA - Ucraina 249
FR - Francia 243
BR - Brasile 189
IE - Irlanda 176
KR - Corea 140
NL - Olanda 128
CI - Costa d'Avorio 127
ZA - Sudafrica 99
EE - Estonia 80
FI - Finlandia 76
CH - Svizzera 75
JP - Giappone 71
TG - Togo 63
BG - Bulgaria 62
CA - Canada 49
ID - Indonesia 42
SC - Seychelles 40
IR - Iran 38
AR - Argentina 35
TR - Turchia 35
ES - Italia 34
BE - Belgio 33
JO - Giordania 33
AT - Austria 30
MX - Messico 26
PL - Polonia 26
GR - Grecia 25
EC - Ecuador 22
BD - Bangladesh 21
CZ - Repubblica Ceca 16
PT - Portogallo 16
TW - Taiwan 15
HR - Croazia 14
CL - Cile 12
TH - Thailandia 12
DK - Danimarca 11
NG - Nigeria 11
PK - Pakistan 11
AU - Australia 9
RO - Romania 8
SI - Slovenia 7
EU - Europa 6
MY - Malesia 6
PH - Filippine 6
TN - Tunisia 6
DZ - Algeria 5
NZ - Nuova Zelanda 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
IL - Israele 4
IQ - Iraq 4
LB - Libano 4
LT - Lituania 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
CO - Colombia 3
MA - Marocco 3
UY - Uruguay 3
AZ - Azerbaigian 2
CM - Camerun 2
GI - Gibilterra 2
KZ - Kazakistan 2
MK - Macedonia 2
NC - Nuova Caledonia 2
NO - Norvegia 2
SM - San Marino 2
UG - Uganda 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BN - Brunei Darussalam 1
BW - Botswana 1
EG - Egitto 1
GD - Grenada 1
HN - Honduras 1
HU - Ungheria 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UZ - Uzbekistan 1
Totale 17.211
Città #
Ashburn 1.061
Singapore 1.011
Southend 948
Chandler 610
Fairfield 468
Hong Kong 394
Dong Ket 374
Bologna 327
Santa Clara 323
Wilmington 253
Houston 246
Princeton 230
Woodbridge 225
Hefei 215
Seattle 192
Cambridge 181
Dublin 176
Beijing 174
Ann Arbor 171
Jacksonville 165
Boardman 154
Abidjan 127
Ho Chi Minh City 125
Dallas 120
Seoul 106
Westminster 99
Berlin 90
Hanoi 84
Milan 84
Nanjing 84
Los Angeles 80
Padova 79
Lomé 63
Jinan 62
Sofia 61
Tokyo 60
Shenyang 59
Medford 58
Bern 57
Turin 55
Buffalo 53
New York 53
Helsinki 52
Munich 49
Hebei 46
Guangzhou 44
Saint Petersburg 44
Redmond 42
San Diego 42
Redondo Beach 41
Changsha 40
Falls Church 40
Redwood City 36
Tianjin 36
Amman 33
Shanghai 33
Brussels 32
Des Moines 32
Bengaluru 29
Mülheim 29
Jakarta 28
Nanchang 27
Bremen 25
Dearborn 25
Paris 25
São Paulo 25
Chicago 24
Frankfurt am Main 22
Jiaxing 22
Yubileyny 22
Hangzhou 20
Ottawa 20
Rome 20
Falkenstein 19
Nuremberg 19
Zhengzhou 19
London 18
Amsterdam 17
Lappeenranta 17
Mahé 16
Chennai 15
Phoenix 15
Vienna 15
Hyderabad 14
Istanbul 14
Norwalk 14
Fremont 13
Haiphong 13
Johannesburg 13
Verona 13
Brooklyn 12
Haikou 12
Olalla 12
Taiyuan 12
Xi'an 12
Casalecchio di Reno 11
Da Nang 11
San Francisco 11
San Jose 11
Shenzhen 11
Totale 10.941
Nome #
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 503
STABILITY OF ASCORBIC ACID IN COSMETIC FORMULATION: PROTECTIVE ROLE OF RESVERATROL AND MELATONIN 309
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 286
Advanced analytical methodologies in Alzheimer's disease drug discovery 268
Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease 234
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 218
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo 212
Climate change effects on bread wheat phenology and grain quality: A case study in the north of Italy 209
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 208
Antitumoral Efficacy of Two Turmeric Extracts According to Different Extraction Methods in Hepatocellular Carcinoma Cell Lines 204
Antioxidant and cytoprotective effects of a wheat-derived non specific lipid transfer protein 2 (nsLTP2) on vascular endothelial cells 196
Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth 192
Structural basis for the magnesium-dependent activation of transketolase from Chlamydomonas reinhardtii 189
Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer’s disease 181
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 179
Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes 179
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 178
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 178
ANTIPROLIFERATIVE ACTIVITY OF ENANTIOMERICALLY PURE (R) AND (S)-9-HYDROXYSTEARIC ACID IN HT29 COLON CANCER CELLS. 177
9-Hydroxystearic acid and sulforaphane: two natural HDAC inhibitors with distinct effects on HT29 cells. 177
Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms 175
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 175
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties 175
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3 171
New insights into the altered binding capacity of pharmaceutical-grade human serum albumin: site-specific binding studies by induced circular dichroism spectroscopy 169
ON-LINE GLYCAN RELEASE AND ANALYSIS BY AN INTEGRATED PNGASE F-IMER LC-ESI-Q-TOF APPROACH 168
Isolation and Characterization of Wheat Derived Nonspecific Lipid Transfer Protein 2 (nsLTP2) 168
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 165
HS-SPME-GC-MS for the quantitation and chiral characterization of camphor and menthol in creams 163
A MULTI-METHODOLOGICAL APPROACH FOR BETA-AMYLOID AGGREGATION AND INHIBITION STUDIES 163
AFM study of F-actin on chemically modified surfaces 161
AFM study of F-actin on chemically modified surfaces 161
Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018 161
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 160
In vitro thrombogenicity of drug-eluting and bare metal stents 157
CE Analysis of Basic Proteins and H4 Human Histones using a Pullulan-Coated Capillary 156
Unveiling the Biochemistry of the Epigenetic Regulator SMYD3 155
ALZHEIMER'S DISEASE DRUG DISCOVERY: NEW ANALYTICAL APPROACHES FOR LEAD SELECTION AND OPTIMIZATION PBA 2009 (20h International Symposium on Pharmaceutical and Biomedical Analysis), Agra, India 01-04 Marzo 2009 154
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 153
Amyloid beta-Peptide 25-35 Self Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment 151
Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress 147
Acetylcholinesterase oriented immobilization on nanopatterned bilayered surfaces for biosensing devices 146
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 145
Rapid MALDI-TOF-MS analysis in the study of interaction between whole bacterial cells and human target molecules: binding of Bifidobacterium to human plasminogen 145
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDAC1 INHIBITION BY 9-HSA 143
Immobilized enzyme-based analytical tools in the -omics era: recent advances 143
Headspace solid-phase microextraction gas chromatography-mass spectrometry (HS SPME-GC-MS) determination of odorants in green tea 141
Analytical approaches in Alzheimer’s disease Drug Discovery 141
Redox-sensitive structural features of transketolase from Chlamydomonas reinhardtii (CrTK) 140
AMYLOID-b-PEPTIDE SELF ASSEMBLY KINETICS BY AFM AND MALDI-TOF MASS SPECTROMETRY 139
IMMOBILIZED ENZYMES AS TOOLS IN DRUG DISCOVERY 138
BIOLOGICAL EFFECTS OF A NEW CLASS I HDAC SELECTIVE INHIBITOR IN HT29 COLON CANCER CELLS. 137
New Coumarin derivatives as cholinergic and cannabinoid system modulators 137
Inhibition of β-Amyloid Aggregation in Alzheimer's Disease: The Key Role of (Pro)electrophilic Warheads 136
Development and characterization of beta-secretase monolithic micro-immobilized enzyme reactor for on-line high-performance liquid chromatography studies 136
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 136
null 135
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance 134
Structural characterization of p53 isoforms due to the polymorphism at codon 72 by Mass Spectrometry and Circular Dichroism. 134
Investigating in vitro amyloid peptide 1−42 aggregation: Impact of higher molecular weight stable adducts 134
HEADSPACE SOLID-PHASE MICROEXTRACTION GAS CHROMATOGRAPHY-MASS SPECTROMETRY (HS SPME-GC-MS) DETERMINATION OF ODORANTS IN GREEN TEA 133
Cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 133
Fluorescence biosensing micropatterned surfaces based on immobilized human acetylcholinesterase 133
From combinations to single-molecule polypharmacology—cromolyn-ibuprofen conjugates for alzheimer’s disease 133
UHPLC determination of catechins for the quality control of green tea 131
Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase 130
Towards automation in protein digestion: Development of a monolithic trypsin immobilized reactor for highly efficient on-line digestion and analysis 129
Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors 129
HISTONE POST-TRANSLATIONAL MODIFICATIONS DETERMINED BY HIGH-PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY 127
Role of D(-)-Lactic Acid in Prevention of Chlamydia trachomatis Infection in an In Vitro Model of HeLa Cells 126
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDACs INHIBITION BY SUBEROYLANILIDE HYDROXAMIC ACID. 124
HISTONE POST-TRANSLATIONAL MODIFICATIONS BY HPLC-ESI-MS AFTER HT29 CELL TREATMENT WITH HDACS INHIBITORS. 124
A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017 124
ANALYTICAL STRATEGIES FOR THE CHARACTERIZATION OF PROTEIN AGGREGATION AND INHIBITION IN HUMAN DISEASES 123
- Application of an ESI-MS method enabling the discovery of new non-ATP competitive GSK-3beta inhibitors. 123
Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry 122
GA‐RAGE – Effetti dell’albumina glicata plasmatica sulla stimolazione di RAGE nel diabete mellito di tipo 2 con complicanze renali 122
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors 121
Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach. 120
EPITOPE IDENTIFICATION OF GLYCATED HSA AND THE EXTRACELLULAR REGION OF HUMAN RAGE BY SPR AND AFFINITY-MS SPECTROMETRY 120
HPLC determination of β-secretase activity on monolithic CIM disks 118
PROTEIN GLYCOSILATION ANALYSIS BY AN INTEGRATED PNGASE-F-IMER-LC-ESI-Q-TOF APPROACH 118
Hystones’ isoforms determined by HPLC-MS 117
Polycyclic Maleimide-based Scaffold as New Privileged Structure for Navigating the Cannabinoid System Opportunities 117
HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy–an in vitro exploration 116
Development of Beta-secretase monolithic micro-imer (immobilized enzyme reactor) for on-line HPLC studies 116
Histones post-translational modifications in colon cancer cell line determined by HPLC-ESI-MS and Maldi-Tof for the characterization of deacetylase inhibitors 116
ACETYLCHOLINESTERASE-BASED ANALYTICAL TOOLS FOR DRUG SCREENING 116
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects 116
Application of ESI-MS method for detailed characterization of GSK-3β inhibitors by monitoring GSM peptide phosphorylation.Angelini Farmaceutici. 115
Interaction between commercial glycated HSA and the extracellular region of human RAGE: a SPR-based study 115
Application of an ESI-MS method enabling the discovery of new non-ATP competitive GSK-3beta inhibitors. 113
Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors. 112
The cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 112
The role of Chromatography in Alzheimer’s Disease Drug Discovery. 109
Evidence of class I HDACs inhibition and cell cycle block in human carcinoma cells after (R) or (S)-9- HSA treatment 107
Unveiling the molecular mechanisms underpinning biorecognition of early-glycated human serum albumin and receptor for advanced glycation end products 105
Development of beta-secretase monolithic micro-IMER: characterization, activity and inhibition studies 103
UHPLC ANALYSIS OF CATECHINS IN GREEN TEAS 103
A multi-methodological approach for the investigation of β-Amyloid-CORMs interaction: an LC-ESI/MS and Circular Dichroism study. 103
Totale 15.299
Categoria #
all - tutte 48.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.068


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.177 0 0 0 0 0 68 71 125 155 89 99 570
2021/20222.278 257 85 93 124 213 128 67 198 114 177 422 400
2022/20232.561 225 315 157 330 195 210 61 186 398 110 190 184
2023/20241.321 59 125 66 86 72 154 235 307 43 59 86 29
2024/20252.960 145 432 305 217 488 160 211 108 55 178 135 526
2025/20263.285 499 721 636 475 757 197 0 0 0 0 0 0
Totale 17.608